Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.83)
# 859
Out of 4,479 analysts
20
Total ratings
63.16%
Success rate
6.4%
Average return
Main Sectors:
12 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $16.48 | +224.64% | 1 | Jun 14, 2024 | |
TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $18.15 | +120.39% | 3 | May 2, 2024 | |
LQDA Liquidia | Maintains: Buy | $15 → $30 | $12.04 | +149.17% | 2 | Dec 21, 2023 | |
ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $7.57 | +12.29% | 3 | Aug 3, 2023 | |
UTHR United Therapeutics | Maintains: Buy | $256 → $268 | $319.01 | -15.99% | 3 | Aug 3, 2023 | |
AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $14.12 | +13.31% | 1 | May 2, 2023 | |
KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $4.35 | +24,520.69% | 2 | Feb 8, 2023 | |
XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.64 | +3,515.78% | 1 | Jun 29, 2022 | |
RPHM Reneo Pharmaceuticals | Initiates: Buy | n/a | $1.55 | - | 1 | Nov 22, 2021 | |
LPCN Lipocine | Upgrades: Buy | n/a | $7.72 | - | 1 | Dec 10, 2020 | |
COGT Cogent Biosciences | Initiates: Buy | n/a | $8.94 | - | 1 | Oct 14, 2020 | |
TARA Protara Therapeutics | Initiates: Buy | n/a | $2.09 | - | 1 | Jan 22, 2020 |
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $16.48
Upside: +224.64%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $18.15
Upside: +120.39%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $12.04
Upside: +149.17%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $7.57
Upside: +12.29%
United Therapeutics
Aug 3, 2023
Maintains: Buy
Price Target: $256 → $268
Current: $319.01
Upside: -15.99%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $14.12
Upside: +13.31%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $4.35
Upside: +24,520.69%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.64
Upside: +3,515.78%
Reneo Pharmaceuticals
Nov 22, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $7.72
Upside: -
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: n/a
Current: $8.94
Upside: -
Protara Therapeutics
Jan 22, 2020
Initiates: Buy
Price Target: n/a
Current: $2.09
Upside: -